| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |